{"raw_mentions": "As used herein, an antibody \u201cbinding to human HLA-G\u201d, \u201cspecifically binding to human HLA-G\u201d, \u201cthat binds to human HLA-G\u201d or \u201canti-HLA-G antibody\u201d refers to an antibody specifically binding to the human HLA-G antigen or its extracellular domain (ECD) with a binding affinity of a K<sub>D</sub>-value of 5.0\u00d710<sup>\u22128 </sup>mol/l or lower, in one embodiment of a K<sub>D</sub>-value of 1.0\u00d710<sup>\u22129 </sup>mol/1 or lower, in one embodiment of a K<sub>D</sub>-value of 5.0\u00d710<sup>\u22128 </sup>mol/1 to 1.0\u00d710<sup>\u221213 </sup>mol/l."}
{"final_json": [{"molecule_name": "anti-HLA-G antibody", "protein_target_name": "human HLA-G antigen", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "5.0\u00d710\u22128", "unit": "mol/l"}, {"molecule_name": "anti-HLA-G antibody", "protein_target_name": "human HLA-G antigen", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "1.0\u00d710\u22129", "unit": "mol/1"}, {"molecule_name": "anti-HLA-G antibody", "protein_target_name": "human HLA-G antigen", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "5.0\u00d710\u22128", "unit": "mol/1"}, {"molecule_name": "anti-HLA-G antibody", "protein_target_name": "human HLA-G antigen", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "1.0\u00d710\u221213", "unit": "mol/l"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:33 and a VL sequence of SEQ ID NO:34 (as determined in surface plasmon resonance assay).\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:33 and a VL sequence of SEQ ID NO:34 (as determined in surface plasmon resonance assay);"}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:15 and a VL sequence of SEQ ID NO:16 (as determined in surface plasmon resonance assay);\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:15 and a VL sequence of SEQ ID NO:16 (as determined in surface plasmon resonance assay);"}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:23 and a VL sequence of SEQ ID NO:24 (as determined in surface plasmon resonance assay);\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:23 and a VL sequence of SEQ ID NO:24 (as determined in surface plasmon resonance assay);"}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nand wherein the antibody binds to HLA-G \u00df2M MHC I complex comprising SEQ ID NO: 43 with a binding affinity which is substantially the same as (in one embodiment with a KD value of the binding affinity is reduced at most 10-fold compared to, in one embodiment with a KD value of the binding affinity is reduced at most 5-fold compared to) an antibody comprising a VH sequence of SEQ ID NO:31 and a VL sequence of SEQ ID NO:32 (as determined in surface plasmon resonance assay).\n\nIn certain embodiments, an antibody provided herein has a dissociation constant KD of \u22641 \u03bcM, \u2264100 nM, \u226410 nM, \u22641 nM, \u22640.1 nM, \u22640.01 nM, or \u22640.001 nM (e.g., 10^{\u22128 } M or less, e.g., from 10^{\u22128 } M to 10^{\u221213 } M, e.g., from 10^{\u22129 } M to 10^{\u221213 } M)."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "HLA-G \u00df2M MHC I complex", "protein_uniprot_id": null, "protein_seq_id": "SEQ ID NO: 43", "binding_metric": "KD", "value": "<=0.001", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22641", "unit": "\u03bcM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u2264100", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u226410", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22641", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.1", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.01", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "10^{\u22128}", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "10^{\u22129}", "unit": "M"}, {"molecule_name": "antibody", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "10^{\u221213}", "unit": "M"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text appears to be a descriptive passage about antibody development, protein purification, and assay methods, but it does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nWt HLA-G was injected (30 \u03bcl/min) at a concentration of 500 nM for 90 seconds.\nTABLEBinding of HLA-G antibodies to recombinant soluble HLA-G MHC class 1 complex, in its monomeric, dimeric and trimeric form (ELISA)HLA-GHLA-GHLA-GMonomerDimerTrimerantibodyEC50 [nM]EC50 [nM]EC50 [nM]HLA-G-00317.191.871.86HLA-G-00397.354.105.29HLA-G-00414.955.314.87HLA-G-0090n.a.n.a.n.a.\nHLA-G wt versus HLA-G degraft binding ELISA:wt HLA-G HLA-A consensus on (SEQ ID NO: 43)HLA-G degraft (monomer)(SEQ ID NO: 44)EC50 relEC50 relAntibody[ng/ml]Max. OD[ng/ml]Max. ODHLA-G-00317.191.6\u20140.13HLA-G-00397.351.4\u20140.13HLA-G-00418.602.3\u20140.15HLA-G-009010.373.4\u20140.2\nwt HLA-G (SEQ ID NO: 25)HLA-A consensus on HLA-G degraft(monomer)(SEQ ID NO: 26)kakd t 1/2kakdt 1/2Anti-body(1/Ms)(1/s)(min)KD (M)(1/Ms)(1/s)(min)KD (M)HLA-G-4.9E+043.7E\u22120337.5E\u221208\u2014\u2014\u2014\u20140031HLA-G-8.3E+04 2.0E\u22120362.4E\u2212080031-0104(humanized)HLA-G- 4.6E+054.4E\u221204279.5E\u221210\u2014\u2014\u2014\u20140039HLA-G-3.8E+054.9E\u221204231.3E\u221209\u2014\u2014\u2014\u20140041HLA-G- 2.3E+058.5E\u221204143.6E\u221209\u2014\u2014\u2014\u20140090\nNon-biotinylated HLA-G molecules were injected for 180 s at 30 \u03bcl/min with concentrations from 2.5 up to 800 nM (2\u00d71:2 and 4\u00d71:3 dilution series) onto the surface (association phase)."}
{"final_json": [{"molecule_name": "HLA-G", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "500", "unit": "nM"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "17.19", "unit": "nM"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "1.87", "unit": "nM"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "1.86", "unit": "nM"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "43", "binding_metric": "EC50 rel", "value": "17.19", "unit": "ng/ml"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "43", "binding_metric": "Max. OD", "value": "1.6", "unit": null}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "44", "binding_metric": "EC50 rel", "value": "0.13", "unit": null}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "25", "binding_metric": "ka", "value": "4.9E+04", "unit": "1/Ms"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "25", "binding_metric": "kd", "value": "3.7E\u221203", "unit": "1/s"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "25", "binding_metric": "t 1/2", "value": "37.5E\u221208", "unit": "min"}, {"molecule_name": "HLA-G-003", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": "25", "binding_metric": "KD", "value": "\u2014\u2014\u2014", "unit": "M"}, {"molecule_name": "HLA-G-031", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "7.35", "unit": "nM"}, {"molecule_name": "HLA-G-031", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "4.10", "unit": "nM"}, {"molecule_name": "HLA-G-031", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "5.29", "unit": "nM"}, {"molecule_name": "HLA-G-004", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "4.95", "unit": "nM"}, {"molecule_name": "HLA-G-004", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "5.31", "unit": "nM"}, {"molecule_name": "HLA-G-004", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "4.87", "unit": "nM"}, {"molecule_name": "HLA-G-009", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "n.a.", "unit": null}, {"molecule_name": "HLA-G", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "2.5", "unit": "nM"}, {"molecule_name": "HLA-G", "protein_target_name": "HLA-G", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "800", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nkakdt 1/2KDAntigenAntibody(1/Ms)(1/s)(Min)(M)wt HLA-GMEM/G91.5E+051.1E\u221203107.7E\u221209(SEQ ID87G\u2014\u2014\u2014\u2014NO: 43)G2331.8E+053.7E\u22120332.0E\u221208(monomer)2A12\u2014\u2014\u2014\u20144H84\u2014\u2014\u2014\u20145A6G7\u2014\u2014\u2014\u20146D463\u2014\u2014\u2014\u20149-1F10\u2014\u2014\u2014\u2014MEM-G/1\u2002\u2014\u2014\u2014\u2014MEM-G/117.4E+048.5E\u221204141.2E\u221208MEM-G/2\u2002\u2014\u2014\u2014\u2014MEM-G/4\u2002\u2014\u2014\u2014\u2014HLA-AMEM/G91.2E+053.6E\u2212020.33.0E\u221207consensus on87G\u2014\u2014\u2014\u2014HLA-G degraftG233\u2014\u2014\u2014\u2014(SEQ ID2A12\u2014\u2014\u2014\u2014NO: 44)4H84\u2014\u2014\u2014\u20145A6G7\u2014\u2014\u2014\u20146D463\u2014\u2014\u2014\u20149-1F10\u2014\u2014\u2014\u2014MEM-G/1\u2002\u2014\u2014\u2014\u2014MEM-G/118.9E+041.2E\u221203101.3E\u221208MEM-G/2\u2002\u2014\u2014\u2014\u2014MEM-G/4\u2002\u2014\u2014\u2014\u2014\nOnly antibody MEM/G9 with a KD value of the binding affinity of 7.7E\u221209 M, antibody G233 with a KD value of 2.0E\u221208 M and MEM-G/11 with a KD value of the binding affinity of 1.2E\u221208 M showed binding to monomeric wt human HLA-G MHC I complex. \nStreptavidin coated plates (NUNC\u2122, MicroCoat #11974998001) were coated with 25 \u03bcl/well biotinylated human wt HLA-G at a concentration of 500-1000 ng/ml and incubated at 4\u00b0 C. overnight."}
{"final_json": [{"molecule_name": "MEM/G9", "protein_target_name": "wt human HLA-G MHC I complex", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "7.7E\u221209", "unit": "M"}, {"molecule_name": "G233", "protein_target_name": "wt human HLA-G MHC I complex", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "2.0E\u221208", "unit": "M"}, {"molecule_name": "MEM-G/11", "protein_target_name": "wt human HLA-G MHC I complex", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1.2E\u221208", "unit": "M"}, {"molecule_name": "human wt HLA-G", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "500-1000", "unit": "ng/ml"}]}
